-
-
-
-
-
-
-
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
-
-
-
-
-
-
-
Corrected Results of Joint Special Shareholder Meeting of Certain Eaton Vance Closed-End Funds
-
-
-
-
-
-
-
Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
-
-
-
-
-
-
-
Evotec Expands iPSC Drug Discovery Leadership Through Strategic Collaboration with Censo Biotechnologies
-
-
-
-
-
-
-
Evotec AG Reports Results of First Nine Months of 2016
-
-
-
-
-
-
-
Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

